Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids

One major challenge associated with lung cancer organoids (LCOs) is their predominant derivation from surgical specimens of patients with early-stage lung cancer. However, patients with advanced lung cancer, who are in need of chemotherapy, often cannot undergo surgery. Therefore, there is an urgent...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dongil, Lee, Dahye, Kim, Yoonjoo, Park, Yeonhee, Lee, Yeon-Jae, Lee, Jeong Eun, Yeo, Min-Kyung, Kang, Min-Woong, Chong, Yooyoung, Han, Sung Joon, Choi, Jinwook, Park, Jong-Eun, Koh, Yongjun, Lee, Jaehyeok, Park, YongKeun, Kim, Ryul, Lee, Jeong Seok, Choi, Jimin, Lee, Sang-Hyun, Ku, Bosung, Kang, Da Hyun, Chung, Chaeuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377875/
https://www.ncbi.nlm.nih.gov/pubmed/37508518
http://dx.doi.org/10.3390/cells12141854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377875/
https://www.ncbi.nlm.nih.gov/pubmed/37508518
http://dx.doi.org/10.3390/cells12141854

Ejemplares similares